Issue 16 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

30

No.

16

April 16, 2004Apr 16, 2004

Free

DOWNLOAD THE PDF

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

NCI reassigns project officer John Gohagan.

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

Kansas Cancer Institute gets $15 million pledge, is renamed, and hires a new director in effort to win NCI center grant.

Funding opportunities listed.

Recent Issues

Volume 51 | Issue 14 - April 11, 2025

Volume 51 | Issue 13 - April 04, 2025

Volume 51 | Issue 12 - March 28, 2025

Volume 51 | Issue 11 - March 21, 2025

Volume 51 | Issue 10 - March 14, 2025

Volume 51 | Issue 09 - March 07, 2025